Physician Use of Non-English Language Skills in Cancer Care

August 22, 2023 updated by: Memorial Sloan Kettering Cancer Center
The purpose of this study is to test a method for analyzing interactions between patients and doctors, the Roter Interaction Analysis System (RIAS). The RIAS measures the quality of communication between patients and their cancer doctors.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

71

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New York
      • Bronx, New York, United States
        • Lincoln Medical Center
      • Jamaica, New York, United States, 11432
        • Queens Cancer Center of Queens Hospital
      • New York, New York, United States, 10065
        • Memorial Sloan Kettering Cancer Center
      • New York, New York, United States
        • Ralph Lauren Center for Cancer Care and Prevention
      • Queens, New York, United States, 11373
        • Elmhurst Hospital Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study will enroll all treating physicians of participating sites who are likely to treat LEP Spanish-speaking patients. All patient recruitment will be done by bilingual research staff who are consenting professionals with (when necessary) a volunteer affiliation with the collaborating study site.

Description

Inclusion Criteria:

  • is a English or Spanish-speaking patient
  • between the ages of 21-80 years old
  • has a new diagnosis of any type of cancer (diagnosed within the past 4 months), or has a recurrence of either breast, colon or lung cancer (recurrence diagnosed within the past 4 months)
  • scheduled to have surgery or begin chemotherapy and/or radiation therapy within the next 2 months

Oncology clinician Inclusion:

  • provides care to LEP patients
  • has MD, DO, RN, NP or PA degree
  • is between the ages of 21-80

Exclusion Criteria:

  • is unable to provide informed consent in either English or Spanish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Oncology physician
Physicians (MD or DO) in the oncology departments of participating hospitals will complete a survey. Non-English language proficiency will be assessed by self-assessment using Interagency Language Roundtable (ILR) scale, which the PI has previously used. The physician survey is collected among treating physicians of patients enrolled to MSK IRB approved protocols 12-099 and 12-223 at some of the participating hospitals. For physicians who already completed this survey as part of participation in protocol 12-099 or 12-223, data will be extracted from the respective study's REDCap database.
Behavioral: survey
The ILR Scale, a non-English language proficiency self-assessment.
Other Names:
  • ILR Scale
Behavioral: Audio record
Audio record the initial visits between patients and their treating physician
patients
Audio record the initial visits between patients and their treating physician. Analyze 48 patient-physician dyad recordings using the Roter Interaction Analysis System (RIAS).
Behavioral: Audio record
Audio record the initial visits between patients and their treating physician

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
study-specific coding structure
Time Frame: 2 years
using the RIAS in cancer care across English and Spanish languages will be assessed by evaluating whether this existing, validated coding system 'works' across a language barrier.
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

Johns Hopkins University
Lincoln Medical and Mental Health Center
Queens Cancer Center of Queens Hospital
Edward-Elmhurst Health System

Investigators

  • Principal Investigator: Lisa Diamond, MD, MPH, Memorial Sloan Kettering Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 14, 2015

Primary Completion (Actual)

August 21, 2023

Study Completion (Actual)

August 21, 2023

Study Registration Dates

First Submitted

March 15, 2016

First Submitted That Met QC Criteria

March 31, 2016

First Posted (Estimated)

April 1, 2016

Study Record Updates

Last Update Posted (Actual)

August 23, 2023

Last Update Submitted That Met QC Criteria

August 22, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 15-316

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on survey

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe